1. Home
  2. TENX vs ANY Comparison

TENX vs ANY Comparison

Compare TENX & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • ANY
  • Stock Information
  • Founded
  • TENX 1967
  • ANY N/A
  • Country
  • TENX United States
  • ANY United States
  • Employees
  • TENX N/A
  • ANY N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • TENX Health Care
  • ANY Finance
  • Exchange
  • TENX Nasdaq
  • ANY Nasdaq
  • Market Cap
  • TENX 21.7M
  • ANY 25.2M
  • IPO Year
  • TENX N/A
  • ANY N/A
  • Fundamental
  • Price
  • TENX $6.75
  • ANY $0.67
  • Analyst Decision
  • TENX Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • TENX 4
  • ANY 1
  • Target Price
  • TENX $20.67
  • ANY $3.00
  • AVG Volume (30 Days)
  • TENX 53.9K
  • ANY 366.5K
  • Earning Date
  • TENX 03-27-2025
  • ANY 03-12-2025
  • Dividend Yield
  • TENX N/A
  • ANY N/A
  • EPS Growth
  • TENX N/A
  • ANY N/A
  • EPS
  • TENX N/A
  • ANY N/A
  • Revenue
  • TENX N/A
  • ANY $21,657,000.00
  • Revenue This Year
  • TENX N/A
  • ANY N/A
  • Revenue Next Year
  • TENX N/A
  • ANY N/A
  • P/E Ratio
  • TENX N/A
  • ANY N/A
  • Revenue Growth
  • TENX N/A
  • ANY 38.44
  • 52 Week Low
  • TENX $2.77
  • ANY $0.66
  • 52 Week High
  • TENX $7.89
  • ANY $2.60
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.52
  • ANY 30.11
  • Support Level
  • TENX $6.10
  • ANY $0.72
  • Resistance Level
  • TENX $7.69
  • ANY $0.76
  • Average True Range (ATR)
  • TENX 0.53
  • ANY 0.06
  • MACD
  • TENX -0.07
  • ANY -0.00
  • Stochastic Oscillator
  • TENX 44.12
  • ANY 2.49

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: